Physicians

Department / Division
Pediatrics / Pediatrics-Infectious Diseases

Address
DUMC 3461
Durham, NC 27710

Appointment Telephone
919-684-6335

Office Telephone
919-668-9000

Fax Telephone
919-668-5239

Training

• MD, University of Rochester School of Medicine and Dentistry (New York), 1979

Residency

• Pediatrics, Duke University Medical Center, 1979-1982

Fellowship

• Pediatric Infectious Diseases, Duke University Medical Center, 1982-1985

Clinical Interests
Pediatric HIV infection and AIDS, evaluation of recurrent infections, evaluation of fevers of unknown origin (FUO)

Research Interests
RESEARCH ABSTRACT

Dr. Ross McKinney's research is in the antiretroviral treatment of HIV infected children, and he has additionally published articles on the natural history and pathogenesis of pediatric HIV disease. Dr. McKinney chaired Pediatric AIDS Clinical Trials Group Protocol 300, a large (600 patient) study of zidovudine, didanosine, and lamivudine in HIV infected children. He recently Co-chaired PACTG 1021 (A phase I-II study of FTC, DDI, and efavirenz), and PACTG 390/PenPact 1 (an international study of treatment strategies for therapy naive children). Dr. McKinney also cochaired PACTG 247, a study of nutritional supplementation in HIV exposed and infected infants.

As of July 2007, Dr. McKinney became the director of the Trent Center for Bioethics, Humanities, and History of Medicine in the Duke University School of Medicine. His current research involves the ethics of medical research, with a particular focus on conflict of interest and on the informed consent process.

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• National Football League Players Association

Representative Publications
McKinney, RE; Cunningham, CK. Newer treatments for HIV in children. Current Opinion in Pediatrics. 2004;16:76-79. (2004) Abstract

Benjamin, DK; Miller, WC; Benjamin, DK; Ryder, RW; Weber, DJ; Walter, E; McKinney, RE. A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS. 2003;17:2331-2336. (2003) Abstract

McKinney, RE; Johnson, GM; Stanley, K; Yong, FH; Keller, A; O'Donnell, KJ; Brouwers, P; Mitchell, WG; Yogev, R; Wara, DW; Wiznia, A; Mofenson, L; McNamara, J; Spector, SA. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. Journal of Pediatrics. 1998;133:500-508. (1998) Abstract

McKinney, RE; Wilfert, C. Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group. Journal of Pediatrics. 1994;125:728-733. (1994) Abstract

McKinney, RE; Maha, MA; Connor, EM; Feinberg, J; Scott, GB; Wulfsohn, M; McIntosh, K; Borkowsky, W; Modlin, JF; Weintrub, P. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. New England Journal of Medicine. 1991;324:1018-1025. (1991) Abstract

McKinney, RE; Pizzo, PA; Scott, GB; Parks, WP; Maha, MA; Lehrman, SN; Riggs, M; Eddy, J; Lane, BA; Eppes, SC. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. Journal of Pediatrics. 1990;116:640-647. (1990) Abstract